INVIVYD, INC. Depreciation
INVIVYD, INC. (IVVD) reported Depreciation of $382.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2024-11-14
- INVIVYD, INC. depreciation for the quarter ending 2024-09-30 was $132.00K, a 10.92% increase year-over-year.
- INVIVYD, INC. depreciation for the quarter ending 2024-06-30 was $128.00K, a 5.79% increase year-over-year.
- INVIVYD, INC. depreciation for the quarter ending 2024-03-31 was $122.00K, a 1.67% increase year-over-year.
- INVIVYD, INC. depreciation for the quarter ending 2023-12-31 was $120.00K, a 344.44% increase year-over-year.
- INVIVYD, INC. depreciation for fiscal 2023 was $480.00K, a 1070.73% increase from fiscal 2022.
- INVIVYD, INC. depreciation for fiscal 2022 was $41.00K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 7 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | $132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $260.00K derived: sum of 2 quarters · filed 2024-11-14 | $382.00K 10-Q · filed 2024-11-14 | $502.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2024-06-30 | $128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $250.00K 10-Q · filed 2024-08-14 | $370.00K derived: sum of 3 quarters · filed 2024-08-14 | $489.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2024-03-31 | $122.00K 10-Q · filed 2024-05-09 | $242.00K derived: sum of 2 quarters · filed 2024-05-09 | $361.00K derived: sum of 3 quarters · filed 2024-11-14 | $482.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-12-31 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $239.00K derived: sum of 2 quarters · filed 2024-11-14 | $360.00K derived: sum of 3 quarters · filed 2024-11-14 | $480.00K 10-K · filed 2024-03-28 | |
| 2023-09-30 | $119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $240.00K derived: sum of 2 quarters · filed 2024-11-14 | $360.00K 10-Q · filed 2024-11-14 | $387.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $241.00K 10-Q · filed 2024-08-14 | $268.00K derived: sum of 3 quarters · filed 2024-08-14 | $273.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $120.00K 10-Q · filed 2024-05-09 | $147.00K derived: sum of 2 quarters · filed 2024-05-09 | $152.00K derived: sum of 3 quarters · filed 2024-05-09 | $157.00K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $32.00K derived: sum of 2 quarters · filed 2024-03-28 | $37.00K derived: sum of 3 quarters · filed 2024-03-28 | $41.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $10.00K derived: sum of 2 quarters · filed 2023-11-09 | $14.00K 10-Q · filed 2023-11-09 | $15.00K derived: sum of 4 quarters · filed 2024-02-09 | |
| 2022-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $9.00K 10-Q · filed 2023-08-10 | $10.00K derived: sum of 3 quarters · filed 2024-02-09 | $10.00K derived: sum of 4 quarters · filed 2024-02-09 | |
| 2022-03-31 | $4.00K 10-Q · filed 2023-05-11 | $5.00K derived: sum of 2 quarters · filed 2024-02-09 | $5.00K derived: sum of 3 quarters · filed 2024-02-09 | $5.00K derived: sum of 4 quarters · filed 2024-02-09 | |
| 2021-12-31 | $1.00K derived: 8-K 12 month − 10-Q 9 month · filed 2024-02-09 | $1.00K derived: sum of 2 quarters · filed 2024-02-09 | $1.00K derived: sum of 3 quarters · filed 2024-02-09 | $1.00K 8-K · filed 2024-02-09 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-13 | ||||
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |